Effect of Rifaximin Treatment on Endotoxemia and Insulin Sensitivity in Humans.
Brian S FinlinBeibei ZhuTania BoyechkoPhilip M WestgateChee W ChiaJosephine M EganPhilip A KernPublished in: Journal of the Endocrine Society (2019)
Rifaximin treatment did not lower plasma LPS or improve metabolic homeostasis in obese humans.